As Mr. Harrington has referred to, the labelling changes were passed into law in 2022. Those are to start being enforced early next year. Those labelling changes will essentially make NHPs a lot more similar to over-the-counter medication packaging—essentially drug packaging.
We have a cost recovery proposal that is now in its second consultation, which has closed down. This must be one of the consultations being counted, which was on cost recovery. Regardless of anything, that is set to go into the Gazette, part II in spring 2025, and the industry will be faced with cost recovery fees as of December 1, 2025.
We have these two omnibus bills, Bill C-47 and Bill C-69. We also have new good manufacturing practice guidance and quality guidance that is coming out. The one that was written before was written in conjunction with the department and industry, and the new one seems to be very similar to what is out for pharmaceuticals.